View in EDS HTML Full Text PDF Full Text

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

Saved in:
Bibliographic Details
Title: Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Authors: Suárez-García I; Infectious Diseases Group, Department of Internal Medicine, Hospital Universitario Infanta Sofia, FIIB HUIS HUHEN, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Clinical Department, Facultad de Medicina, Salud y Deporte, Universidad Europea de Madrid, Madrid, Spain., Alejos B; Independent Researcher, Madrid, Spain., Moreno C; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Martín Torres J; HIV Unit, Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Masiá M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Section, Department of Internal Medicine, Hospital General Universitario de Elche, Alicante, Spain.; Department of Clinical Medicine, Universidad Miguel Hernández de Elche, Alicante, Spain., García-Fraile LJ; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario de La Princesa, Madrid, Spain., Riera M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Internal Medicine, Section of Infectious Diseases, Hospital Universitario Son Espases-IDISBA, Palma, Spain., Dalmau D; HIV/STI/PrEP Unit, Infectious Disease Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain., Rodríguez-Rosado R; Department of Internal Medicine, Hospital Universitario Severo Ochoa, Madrid, Spain., Muga R; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno S; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain.; Department of Medicine, Universidad de Alcalá, Madrid, Spain., Jarrín I; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.
Corporate Authors: CoRIS cohort
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Mar 03; Vol. 80 (3), pp. 682-691.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39710424
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Suárez-García+I%22">Suárez-García I</searchLink>; Infectious Diseases Group, Department of Internal Medicine, Hospital Universitario Infanta Sofia, FIIB HUIS HUHEN, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Clinical Department, Facultad de Medicina, Salud y Deporte, Universidad Europea de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alejos+B%22">Alejos B</searchLink>; Independent Researcher, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+C%22">Moreno C</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martín+Torres+J%22">Martín Torres J</searchLink>; HIV Unit, Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Masiá+M%22">Masiá M</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Section, Department of Internal Medicine, Hospital General Universitario de Elche, Alicante, Spain.; Department of Clinical Medicine, Universidad Miguel Hernández de Elche, Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22García-Fraile+LJ%22">García-Fraile LJ</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario de La Princesa, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Riera+M%22">Riera M</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Internal Medicine, Section of Infectious Diseases, Hospital Universitario Son Espases-IDISBA, Palma, Spain.<br /><searchLink fieldCode="AU" term="%22Dalmau+D%22">Dalmau D</searchLink>; HIV/STI/PrEP Unit, Infectious Disease Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Rosado+R%22">Rodríguez-Rosado R</searchLink>; Department of Internal Medicine, Hospital Universitario Severo Ochoa, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Muga+R%22">Muga R</searchLink>; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+S%22">Moreno S</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain.; Department of Medicine, Universidad de Alcalá, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Jarrín+I%22">Jarrín I</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22CoRIS+cohort%22">CoRIS cohort</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2025 Mar 03; Vol. 80 (3), pp. 682-691.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39710424
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jac/dkae456
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 682
    Titles:
      – TitleFull: Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Suárez-García I
      – PersonEntity:
          Name:
            NameFull: Alejos B
      – PersonEntity:
          Name:
            NameFull: Moreno C
      – PersonEntity:
          Name:
            NameFull: Martín Torres J
      – PersonEntity:
          Name:
            NameFull: Masiá M
      – PersonEntity:
          Name:
            NameFull: García-Fraile LJ
      – PersonEntity:
          Name:
            NameFull: Riera M
      – PersonEntity:
          Name:
            NameFull: Dalmau D
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Rosado R
      – PersonEntity:
          Name:
            NameFull: Muga R
      – PersonEntity:
          Name:
            NameFull: Moreno S
      – PersonEntity:
          Name:
            NameFull: Jarrín I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2025 Mar 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2091
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of antimicrobial chemotherapy
              Type: main
ResultId 1